Trials / Completed
CompletedNCT05316311
A Study of Implantation of CRENEOUS ENTERPRISE 2 Intracranial Stent in Participants With Severe Symptomatic Intracranial Atherosclerotic Stenosis
Implantation of CERENOVUS ENTERPRISE 2 Intracranial Stent in Patients With Severe Symptomatic Intracranial Atherosclerotic Stenosis: A Multicenter, Prospective and Single-Arm Study in China
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 194 (actual)
- Sponsor
- Medos International SARL · Industry
- Sex
- All
- Age
- 22 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety and effectiveness of CERENOVUS ENTERPRISE 2 intracranial stent implantation in treatment of participants with severe symptomatic intracranial atherosclerotic stenosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CERENOVUS ENTERPRISE 2 Intracranial Stent | CERENOVUS ENTERPRISE 2 Intracranial Stent will be used to treat severe symptomatic intracranial artery stenosis. |
Timeline
- Start date
- 2022-05-24
- Primary completion
- 2025-12-24
- Completion
- 2026-02-06
- First posted
- 2022-04-07
- Last updated
- 2026-04-01
Locations
14 sites across 1 country: China
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05316311. Inclusion in this directory is not an endorsement.